Last updated: August 29, 2023
Sponsor: Baylor College of Medicine
Overall Status: Completed
Phase
4
Condition
Dysfunctional Uterine Bleeding
Menstrual Disorders
Heavy Bleeding / Heavy Periods
Treatment
Ferrous sulfate
Clinical Study ID
NCT05007899
H - 46363
Ages 9-22 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age 9 years or greater and less than age 22 years
- Heavy menstrual bleeding, defined as a Pictorial Blood Assessment Chart (PBAC) Score >100
- Iron deficiency anemia, defined as both hemoglobin <12 g/dL and ferritin <15 ng/mLwithin 7 days of enrollment.
Exclusion
Exclusion Criteria:
- non-uterine cause of vaginal bleeding
- pregnancy
- chronic kidney disease
- serology confirmed celiac disease
- active gastrointestinal blood loss
- active malignancy
- inability to follow-up at Texas Children's Hospital
- receipt of intravenous iron within 30 days prior to enrollment
- allergy or known inability to tolerate oral iron
Study Design
Total Participants: 13
Treatment Group(s): 1
Primary Treatment: Ferrous sulfate
Phase: 4
Study Start date:
December 21, 2020
Estimated Completion Date:
December 22, 2022
Study Description
Connect with a study center
Texas Children's Pavilion for Women
Houston, Texas 77030
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.